Pharmaceutical industry group sues to stop Minnesota's new insulin-aid program

Star Tribune: A pharmaceutical-industry group is suing the state of Minnesota over its new insulin-affordability program, which took effect Wednesday.

Pharmaceutical Research and Manufacturers of America, or PhRMA, said the program the Legislature passed in April is unconstitutional and that drugmakers already offer alternatives to help people with diabetes. They are seeking a permanent injunction barring the state from enforcing the insulin act.

Read article

Share

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending